A peer-reviewed, multi-clinic study published in the Journal of Assisted Reproduction and Genetics suggests an epigenetic ...
Dr. Piraye Yurttas Beim, Founder and CEO of Celmatix, stated, "Our oral FSH program stands to fundamentally change the landscape of fertility treatments. By offering a non-invasive alternative to ...